07/02/2014 - 12:17pm

Larry Hausner, CEO of the American Diabetes Association, on Tuesday announced that he will step down as CEO, effective July 31, 2014, to pursue new opportunities in his native New York metro area.

07/02/2014 - 11:24am

The makers of Larabar have announced the debut of Renola, a new type of granola made with nuts, fruits, seeds and spices, which the brand is billing as an alternative to classic granola.

07/02/2014 - 11:12am

PepsiCo and 7-Eleven on Wednesday announced the launch of two new food and beverage products for 7-Eleven customers. The companies are debuting Doritos Loaded and Mtn Dew Solar Flare, an exclusive flavor for 7-Eleven's Big Gulp beverages.

07/02/2014 - 10:46am

The bold brow trend is fueling growth within U.S. prestige makeup, according to the NPD Group, a global information company.

07/02/2014 - 10:11am

This Fourth of July, Prilosec OTC is paying tribute to the troops and thanking those who support this country by helping to bring back Fort Bragg’s Independence Day fireworks and celebration.

07/02/2014 - 9:22am

Pinnacle Foods announced on Monday that it has terminated its merger agreement with Hillshire Brands, originally announced May 12. Pinnacle is a producer of such branded food products as Vlasic pickles, Mrs. Butterworth syrups and Wishbone salad dressings.

07/02/2014 - 7:42am

On June 25, the U.S. Department of Justice, at the request of the Food and Drug Administration, filed a complaint for permanent injunction in the U.S. District Court for the Central District of California against Laclede of Rancho Dominguez, Calif., and its president, Michael Pellico.

07/02/2014 - 7:32am

Health care providers wrote 259 million prescriptions for opioid painkillers in 2012 — many more in some states than in others — according to a Vital Signs report released Tuesday by the Centers for Disease Control and Prevention that highlights the danger of overdose.

07/02/2014 - 7:19am

As many as 32 organizations on Tuesday signed a letter calling on the Food and Drug Administration to require biologics and biosimilars to have the same International Nonproprietary Name, a practice currently in use in Europe and other markets.